Literature DB >> 22836869

Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans.

Rita Berardelli1, Ioannis Karamouzis, Valentina D'Angelo, Clizia Zichi, Beatrice Fussotto, Roberta Giordano, Ezio Ghigo, Emanuela Arvat.   

Abstract

This clinical review will summarize the available data regarding the role of mineralocorticoid receptors (MRs) on the hypothalamus-pituitary-adrenal (HPA) axis control in physiological and pathological conditions and in the memory processes involved in the control and appraisal of a stress event. MRs are predominantly expressed in the limbic structures, with the hippocampus being the main localization, although MRs are also found at the hypothalamic level. It is known that hyppocampal MRs control the proactive feedback involved in the maintenance of the basal HPA activity, mainly at the nadir of the circadian rhythm. In physiological conditions, the administration of pharmacological doses of both MR antagonists and agonists is able to interact with the HPA activity, modifying the quiescent phase-nadir of the circadian rhythm, although some data in the literature do not support these observations. Also, in a physiological condition such as aging, an enhanced HPA axis activity is found in the time window, when MRs are predominantly occupied by cortisol circulating levels, possibly reflecting an MR impairment in this period of life. In pathology, major depression has been correlated to MR qualitative-quantitative alterations which could reflect differences on psychological and physiological responses, possibly predicting psychopathologies. Most of the remarks reported in this review seem to indicate, in agreement with animal data, a role played by MRs in the delicate control of the HPA axis in humans and the possible predisposition to the development of pathologies in case of their alterations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836869     DOI: 10.1007/s12020-012-9750-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  92 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

2.  Association of a common mineralocorticoid receptor gene polymorphism with salivary cortisol in healthy adults.

Authors:  Christoph Muhtz; Birgit-Christiane Zyriax; Brigitta Bondy; Eberhard Windler; Christian Otte
Journal:  Psychoneuroendocrinology       Date:  2010-09-15       Impact factor: 4.905

Review 3.  Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance.

Authors:  J W Funder
Journal:  Annu Rev Med       Date:  1997       Impact factor: 13.739

4.  DNA binding of the glucocorticoid receptor is not essential for survival.

Authors:  H M Reichardt; K H Kaestner; J Tuckermann; O Kretz; O Wessely; R Bock; P Gass; W Schmid; P Herrlich; P Angel; G Schütz
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

5.  Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep.

Authors:  J Born; D Steinbach; C Dodt; H L Fehm
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

6.  Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors.

Authors:  Qi Wang; Sarah Anzick; William F Richter; Paul Meltzer; S Stoney Simons
Journal:  J Steroid Biochem Mol Biol       Date:  2004-08       Impact factor: 4.292

Review 7.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

Review 8.  The mineralocorticoid receptor and its coregulators.

Authors:  Jun Yang; Morag J Young
Journal:  J Mol Endocrinol       Date:  2009-08       Impact factor: 5.098

9.  The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.

Authors:  S Grottoli; R Giordano; B Maccagno; M Pellegrino; E Ghigo; E Arvat
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

10.  The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.

Authors:  E A Young; J F Lopez; V Murphy-Weinberg; S J Watson; H Akil
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

View more
  12 in total

1.  Modulation of central glucocorticoid receptors in short- and long-term experimental hyperthyroidism.

Authors:  Elena Nikolopoulou; Dimitrios Mytilinaios; Aldo E Calogero; Themis C Kamilaris; Theodore Troupis; George P Chrousos; Elizabeth O Johnson
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

2.  Volumetric brain differences in clinical depression in association with anxiety: a systematic review with meta-analysis.

Authors:  Daniela A Espinoza Oyarce; Marnie E Shaw; Khawlah Alateeq; Nicolas Cherbuin
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

Review 3.  Oxidative stress and the ageing endocrine system.

Authors:  Giovanni Vitale; Stefano Salvioli; Claudio Franceschi
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

Review 4.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

5.  Long-term glucocorticoid concentrations as a risk factor for childhood obesity and adverse body-fat distribution.

Authors:  G Noppe; E L T van den Akker; Y B de Rijke; J W Koper; V W Jaddoe; E F C van Rossum
Journal:  Int J Obes (Lond)       Date:  2016-06-24       Impact factor: 5.095

6.  The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.

Authors:  R Berardelli; I Karamouzis; V D'Angelo; B Fussotto; M A Minetto; E Ghigo; R Giordano; E Arvat
Journal:  J Endocrinol Invest       Date:  2015-10-08       Impact factor: 4.256

7.  Telencephalic regulation of the HPA axis in birds.

Authors:  Tom V Smulders
Journal:  Neurobiol Stress       Date:  2021-06-10

8.  Juvenile stress enhances anxiety and alters corticosteroid receptor expression in adulthood.

Authors:  Nichola M Brydges; Rowen Jin; Jonathan Seckl; Megan C Holmes; Amanda J Drake; Jeremy Hall
Journal:  Brain Behav       Date:  2013-10-30       Impact factor: 2.708

9.  Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia.

Authors:  J Costas; N Carrera; P Alonso; X Gurriarán; C Segalàs; E Real; C López-Solà; S Mas; P Gassó; L Domènech; M Morell; I Quintela; L Lázaro; J M Menchón; X Estivill; Á Carracedo
Journal:  Transl Psychiatry       Date:  2016-03-29       Impact factor: 6.222

10.  Ovine hippocampal mRNA expression in offspring from dams supplemented with fishmeal and stress challenged in late pregnancy with endotoxin.

Authors:  Niel A Karrow; Alison V Lee; Margaret Quinton; Brian W McBride; Rebecca E Fisher-Heffernan
Journal:  Anim Nutr       Date:  2016-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.